Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
MediWound announced the expansion of its agreement with GENFA MEDICA, granting it the exclusive right to market and distribute NexoBrid® in Ukraine, Lithuania, Latvia, and Estonia.
read more
Wednesday, August 26, 2020
MediWound and Vericel announced the BARDA has accepted the first shipment of NexoBrid
read more
Medix Biochemica has acquired 100 percent of the shares of Bioresource Technology ("BRT") to broaden its base matrix capabilities and further strengthen its local presence in the US market.
read more
Friday, November 04, 2022
Medmix Drug Delivery (Haselmeier) and AARDEX Group announced a collaboration, combining Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and hardware ecosystem.
read more
Mednet, a healthcare technology company, announced its latest software release featuring expanded trial supply management capabilities. The new Trial Supply Manager, a component of Mednet's Randomization and Trial Supply Management (RTSM) module, ...
read more
Friday, September 23, 2016
Medoc, a provider of neuro-diagnostic medical systems, has announced its official expansion from supporting academic research to serving the needs of Clinical Research Organizations, yielding improved success probabilities of pharmaceutical clinical ...
read more
MedPharm has announced two new appointments to its Board to support plans to grow its commercial manufacturing services.
read more
MedPharm reported that it is supporting Palvella Therapeutics following Palvella’s announcement of positive topline results from the Phase 3 SELVA study of QTORIN 3.9% rapamycin anhydrous gel in microcystic lymphatic malformations (microcystic LMs).
read more
Friday, February 08, 2019
MedPharm have announced the expansion of their partnership with Palvella, a Philadelphia-based biopharmaceutical company focused on therapies for rare genetic diseases.
read more
Tuesday, November 12, 2019
MedPharm has been named the winner in the Analysis, Testing, and Quality Control category at the prestigious CPhI Pharma Awards 2019.
read more
MedPharm has announced the expansion of its US Center of Excellence in Durham, North Carolina.
read more
Wednesday, February 14, 2018
MedPharm has announced a laboratory expansion following an internal investment of £1 million to increase its laboratory footprint in the UK by 60%.
read more
Wednesday, January 07, 2026
MedPharm announced that its topical drug product manufacturing facility in Durham has successfully completed a U.S. Food and Drug Administration (FDA) inspection for commercial manufacture of drug products.
read more
Wednesday, January 08, 2020
MedPharm has appointed Lynn Allen as VP of Business Development.
read more
Wednesday, February 05, 2025
MedPharm announced the appointment of Bill Humphries as Chief Executive Officer. Bill's leadership will enable MedPharm to accelerate its strategic growth following its merger with Tergus Pharma which significantly bolstered MedPharm's scientific, ...
read more